Leadership at Vanderbilt-Ingram Cancer Center
The Vanderbilt-Ingram Cancer Center is led by a director, a deputy director, and team of associate center directors representing all aspects of the center. A Cancer Clinical Enterprise Committee oversees strategy and decision-making for the clinical operations of the center. Vanderbilt-Ingram Cancer Center is also guided by a volunteer community Board of Overseers and external scientific advisory board.
Executive Leadership Team
- Jennifer A. Pietenpol, Ph.D.
Director, Vanderbilt-Ingram Cancer Center - Lauren Hackett, M.P.A.
Executive Director of Administration and Chief Business Officer - Dan Beauchamp, M.D.
Deputy Director, Vanderbilt-Ingram Cancer Center - Michael N. Neuss, M.D.
Chief Medical Officer - Anna L. Rodriguez, M.S.N., M.H.A
Associate Nursing Officer
Associate Center Directors
- Jordan D. Berlin, M.D.
Associate Director of Clinical Investigation Strategy and Shared Resources - Bill Blot, Ph.D.
Associate Director for Population-Based Research - Scott Hiebert, Ph.D.
Associate Director for Basic Science and Shared Resources - Beth Jones, M.A.
Executive Director of Development - Tuya Pal, M.D.
Associate Director for Cancer Health Disparities - Ann Richmond, Ph.D.
Associate Director for Research Education - Xiao-Ou Shu, M.D., Ph.D.
Associate Director for Global Health - Theresa M. Keske Sberna, M.P.H.
Director, Strategy and Analytics - Julie C. Schaum, M.S.
Associate Director of Research Administration - Yu Shyr, Ph.D.
Associate Director for Quantitative Sciences - Anne Washburn, M.P.H.
Associate Director for Community Engagement, Education, and Affiliations - TBD
Senior Director of Clinical Research Administration
Research Program Leaders
Breast Cancer Research Program
Cancer Epidemiology Research Program
Cancer Health Outcomes and Control Research Program
Gastrointestinal Cancer Research Program
Genome Maintenance Research Program
Host-Tumor Interactions Research Program
Signal Transduction and Chemical Biology Research Program
Translational Research and Interventional Oncology Research Program
Other Key Leaders
- Mia Levy, M.D., Ph.D.
Director, Cancer Health Informatics and Strategy - Georgia Wiesner, M.D., M.S.
Director, Clinical and Translational Hereditary Cancer Program
Executive Committee
- Ronald Alvarez, M.D., M.B.A.
- Dan Beauchamp, M.D.
- Bill Blot, Ph.D.
- Debra L. Friedman, M.D.
- Lauren Hackett, M.P.A.
- Scott Hiebert, Ph.D.
- Beth Jones, M.A.
- Lisa A. Kachnic, M.D.
- Mia Levy, M.D., Ph.D.
- Harold L. Moses, M.D.
- Michael N. Neuss, M.D.
- W. Kimryn (Kim) Rathmell, M.D., Ph.D.
- Ann Richmond, Ph.D.
- Anna L. Rodriguez, M.S.N., M.H.A
- Theresa M. Keske Sberna, M.P.H.
- Julie C. Schaum, M.S.
- Xiao-Ou Shu, M.D., Ph.D.
- Yu Shyr, Ph.D.
- Anne Washburn, M.P.H.
- Mary M. Zutter, M.D.
